Cargando…
Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers
The majority of breast cancer specific deaths in women with estrogen receptor positive (ER(+)) tumors occur due to metastases that are resistant to therapy. There is a critical need for novel therapeutic approaches to achieve tumor regression and/or maintain therapy responsiveness in metastatic ER(+...
Autores principales: | Cotul, Eylem Kulkoyluoglu, Zuo, Qianying, Santaliz-Casiano, Ashlie, Imir, Ozan Berk, Mogol, Ayca Nazli, Tunc, Elif, Duong, Kevin, Lee, Jenna Kathryn, Ramesh, Rithva, Odukoya, Elijah, Kesavadas, Mrinali P., Ziogaite, Monika, Smith, Brandi Patrice, Mao, Chengjian, Shapiro, David J., Park, Ben Ho, Katzenellenbogen, Benita S., Daly, Drew, Aranda, Evelyn, O’Neill, John D., Walker, Christopher, Landesman, Yosef, Madak-Erdogan, Zeynep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563274/ https://www.ncbi.nlm.nih.gov/pubmed/32847042 http://dx.doi.org/10.3390/cancers12092397 |
Ejemplares similares
-
OR09-2 Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2019) -
Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance
por: Kulkoyluoglu-Cotul, Eylem, et al.
Publicado: (2019) -
ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors
por: Mogol, Ayca, et al.
Publicado: (2022) -
THU558 Combination Therapy Of Acetyl-CoA Synthetase Inhibitor And Fulvestrant Reverse Epigenetic Alterations Of Metastatic Breast Cancer Cells And Reduce Cancer Cell Proliferation
por: Mogol, Ayca N, et al.
Publicado: (2023) -
THU486 Identification Of Metabolic And Molecular Mechanisms Driving Estrogen Receptor Positive Breast Cancer Disparities Using A Machine-Learning Pipeline
por: Casiano, Ashlie Santaliz, et al.
Publicado: (2023)